List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Subcutaneous Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Subcutaneous Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Subcutaneous Biologics Overall Market Size
2.1 Global Subcutaneous Biologics Market Size: 2022 VS 2029
2.2 Global Subcutaneous Biologics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Subcutaneous Biologics Players in Global Market
3.2 Top Global Subcutaneous Biologics Companies Ranked by Revenue
3.3 Global Subcutaneous Biologics Revenue by Companies
3.4 Top 3 and Top 5 Subcutaneous Biologics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Subcutaneous Biologics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Subcutaneous Biologics Players in Global Market
3.6.1 List of Global Tier 1 Subcutaneous Biologics Companies
3.6.2 List of Global Tier 2 and Tier 3 Subcutaneous Biologics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Subcutaneous Biologics Market Size Markets, 2022 & 2029
4.1.2 Syringe
4.1.3 Wearable injector
4.1.4 Automatic injector
4.1.5 Implants
4.2 By Type - Global Subcutaneous Biologics Revenue & Forecasts
4.2.1 By Type - Global Subcutaneous Biologics Revenue, 2018-2023
4.2.2 By Type - Global Subcutaneous Biologics Revenue, 2024-2029
4.2.3 By Type - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Subcutaneous Biologics Market Size, 2022 & 2029
5.1.2 Hospital pharmacies
5.1.3 Retail pharmacies
5.1.4 Drug stores
5.1.5 Online pharmacies
5.2 By Application - Global Subcutaneous Biologics Revenue & Forecasts
5.2.1 By Application - Global Subcutaneous Biologics Revenue, 2018-2023
5.2.2 By Application - Global Subcutaneous Biologics Revenue, 2024-2029
5.2.3 By Application - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Subcutaneous Biologics Market Size, 2022 & 2029
6.2 By Region - Global Subcutaneous Biologics Revenue & Forecasts
6.2.1 By Region - Global Subcutaneous Biologics Revenue, 2018-2023
6.2.2 By Region - Global Subcutaneous Biologics Revenue, 2024-2029
6.2.3 By Region - Global Subcutaneous Biologics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Subcutaneous Biologics Revenue, 2018-2029
6.3.2 US Subcutaneous Biologics Market Size, 2018-2029
6.3.3 Canada Subcutaneous Biologics Market Size, 2018-2029
6.3.4 Mexico Subcutaneous Biologics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Subcutaneous Biologics Revenue, 2018-2029
6.4.2 Germany Subcutaneous Biologics Market Size, 2018-2029
6.4.3 France Subcutaneous Biologics Market Size, 2018-2029
6.4.4 U.K. Subcutaneous Biologics Market Size, 2018-2029
6.4.5 Italy Subcutaneous Biologics Market Size, 2018-2029
6.4.6 Russia Subcutaneous Biologics Market Size, 2018-2029
6.4.7 Nordic Countries Subcutaneous Biologics Market Size, 2018-2029
6.4.8 Benelux Subcutaneous Biologics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Subcutaneous Biologics Revenue, 2018-2029
6.5.2 China Subcutaneous Biologics Market Size, 2018-2029
6.5.3 Japan Subcutaneous Biologics Market Size, 2018-2029
6.5.4 South Korea Subcutaneous Biologics Market Size, 2018-2029
6.5.5 Southeast Asia Subcutaneous Biologics Market Size, 2018-2029
6.5.6 India Subcutaneous Biologics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Subcutaneous Biologics Revenue, 2018-2029
6.6.2 Brazil Subcutaneous Biologics Market Size, 2018-2029
6.6.3 Argentina Subcutaneous Biologics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Subcutaneous Biologics Revenue, 2018-2029
6.7.2 Turkey Subcutaneous Biologics Market Size, 2018-2029
6.7.3 Israel Subcutaneous Biologics Market Size, 2018-2029
6.7.4 Saudi Arabia Subcutaneous Biologics Market Size, 2018-2029
6.7.5 UAE Subcutaneous Biologics Market Size, 2018-2029
7 Subcutaneous Biologics Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Subcutaneous Biologics Major Product Offerings
7.1.4 Abbott Laboratories Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Company Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Subcutaneous Biologics Major Product Offerings
7.2.4 Pfizer Inc. Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.2.5 Pfizer Inc. Key News & Latest Developments
7.3 Genentech Inc.
7.3.1 Genentech Inc. Company Summary
7.3.2 Genentech Inc. Business Overview
7.3.3 Genentech Inc. Subcutaneous Biologics Major Product Offerings
7.3.4 Genentech Inc. Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.3.5 Genentech Inc. Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Subcutaneous Biologics Major Product Offerings
7.4.4 Novartis AG Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Biogen Idec
7.5.1 Biogen Idec Company Summary
7.5.2 Biogen Idec Business Overview
7.5.3 Biogen Idec Subcutaneous Biologics Major Product Offerings
7.5.4 Biogen Idec Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.5.5 Biogen Idec Key News & Latest Developments
7.6 AbbVie Inc.
7.6.1 AbbVie Inc. Company Summary
7.6.2 AbbVie Inc. Business Overview
7.6.3 AbbVie Inc. Subcutaneous Biologics Major Product Offerings
7.6.4 AbbVie Inc. Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.6.5 AbbVie Inc. Key News & Latest Developments
7.7 F. Hoffmann-La Roche AG
7.7.1 F. Hoffmann-La Roche AG Company Summary
7.7.2 F. Hoffmann-La Roche AG Business Overview
7.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Major Product Offerings
7.7.4 F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.7.5 F. Hoffmann-La Roche AG Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Subcutaneous Biologics Major Product Offerings
7.8.4 Bristol-Myers Squibb Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Eisai Inc.
7.9.1 Eisai Inc. Company Summary
7.9.2 Eisai Inc. Business Overview
7.9.3 Eisai Inc. Subcutaneous Biologics Major Product Offerings
7.9.4 Eisai Inc. Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.9.5 Eisai Inc. Key News & Latest Developments
7.10 Takeda Pharmaceuticals Ltd.
7.10.1 Takeda Pharmaceuticals Ltd. Company Summary
7.10.2 Takeda Pharmaceuticals Ltd. Business Overview
7.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Major Product Offerings
7.10.4 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.10.5 Takeda Pharmaceuticals Ltd. Key News & Latest Developments
7.11 Alnylam Pharmaceuticals
7.11.1 Alnylam Pharmaceuticals Company Summary
7.11.2 Alnylam Pharmaceuticals Business Overview
7.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Major Product Offerings
7.11.4 Alnylam Pharmaceuticals Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.11.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.12 Bayer AG
7.12.1 Bayer AG Company Summary
7.12.2 Bayer AG Business Overview
7.12.3 Bayer AG Subcutaneous Biologics Major Product Offerings
7.12.4 Bayer AG Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.12.5 Bayer AG Key News & Latest Developments
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Company Summary
7.13.2 GlaxoSmithKline Business Overview
7.13.3 GlaxoSmithKline Subcutaneous Biologics Major Product Offerings
7.13.4 GlaxoSmithKline Subcutaneous Biologics Revenue in Global Market (2018-2023)
7.13.5 GlaxoSmithKline Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
